In 85 patients having IMRT for head and neck cancer, daily intraoral LED photobiomodulation vs sham lowered severe oral mucositis (WHO grade ≥3) over six weeks (36.8% vs 57.1%; p=0.046) and two weeks after IMRT (10.8% vs 36.4%). No device-related adverse events.
RCTn = 85
Hu et al. Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis and associated complications due to radiotherapy for head and neck cancer